Strategy for improving the prognosis of patients with intrahepatic cholangiocarcinoma by surgical treatment : Considerations based on experience and a literature review.
hepatitis virus
hepatocellular carcinoma (HCC)
intrahepatic cholangiocarcinoma (ICC)
lenvatinib
nibolumab
Journal
The journal of medical investigation : JMI
ISSN: 1349-6867
Titre abrégé: J Med Invest
Pays: Japan
ID NLM: 9716841
Informations de publication
Date de publication:
2021
2021
Historique:
entrez:
17
5
2021
pubmed:
18
5
2021
medline:
29
10
2021
Statut:
ppublish
Résumé
The prognosis of patients with intrahepatic cholangiocarcinoma (ICC) is still poor, and the 5-year survival rate in patients undergoing radical surgery (R0) is less than one-third. Since the prognosis depends mainly on tumor factors, so early diagnosis is necessary. To extend the survival time of these patients with a poor prognosis, cases of long-term survival were examined based on the results of our experiences and the literature. It was found that the hepatitis virus was highly involved in the carcinogenesis of ICC, and patients who were infected with hepatitis virus had rather good survival. J. Med. Invest. 68 : 15-21, February, 2021.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM